Adagio Therapeutics Inc.

NASDAQ: ADGI · Real-Time Price · USD
4.64
0.04 (0.87%)
At close: Sep 13, 2022, 6:00 AM

Adagio Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
n/a
Cost of Revenue
n/a
Gross Profit
n/a
Operating Income
-226.79M
Interest Income
n/a
Pretax Income
-226.79M
Net Income
-226.79M
Selling & General & Admin
36.52M
Research & Development
182.89M
Other Expenses
7.5M
Operating Expenses
226.91M
Interest Expense
n/a
Selling & Marketing Expenses
n/a
Cost & Expenses
226.91M
Income Tax Expense
118K
Shares Outstanding (Basic)
111.25M
Shares Outstanding (Diluted)
111.25M
EPS (Basic)
-2.04
EPS (Diluted)
-2.04
EBITDA
-225.36M
EBIT
-226.79M
Depreciation & Amortization
1.43M